Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases

sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases

US Patent 8409815 · Granted Apr 2, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the inhibition of angiogenesis2018
Method for the inhibition of angiogenesis2018
Method for promoting angiogenesis, vascularization or vessel repair or for inhib2016
Method for promoting angiogenesis, vascularization or vessel repair or for inhib2016
Methods for improving cell therapy and tissue regeneration in patients with card2015
Methods for improving cell therapy and tissue regeneration in patients with card2015
Methods for improving cell therapy and tissue regeneration in patients with card2015
Antagonists of miRNA-29 expression and their use in the prevention and treatment2015
Antagonists of miRNA-29 expression and their use in the prevention and treatment2015
Method for treating myocardial infarct2014
Method for treating myocardial infarct2014
Micro-RNA for the regulation of cardiac apoptosis and contractile function2014